Functional Shots Surge, Graza Explores Sale, Surgery Gets Scrutinized

September 29, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

• Functional shots emerge as the next supplement ritual, with the category projected to grow from $6.6B to $19B by 2033 as investors back brands like Sol-ti and Suja
• The Economist questions the evidence behind common surgeries, finding roughly two-thirds of patient improvement in trials came from natural healing or placebo effects
• Olive oil brand Graza explores a sale valued between $450M and $600M as larger food companies acquire brands reinventing familiar categories

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider

Reach out → [email protected]